Day One Biopharmaceuticals, Inc.: how funds voted at the meeting of 23 May 2024
- Meeting
- Season
- year to 30 June 2024
- Filers reporting
- 251
- Ballot items
- 4
251 filers on Form N-PX reported votes at the Day One Biopharmaceuticals, Inc. meeting of 23 May 2024. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Day One Biopharmaceuticals, Inc. has the latest meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2024. Filings read through . How the figures are made
The ballot
Item 1: Director elections
3 nominees. 76.6% of the reported votes are for. 41 filers withheld from or voted against at least one nominee.
580 vote records from 94 filers. 28 of the 93 filers that marked the item voted against management. 1 filer gave no management mark.
- Positions of 35 fund families
- For 24
- Abstain or withhold 11
- Against management 11
Item 2: Advisory vote on executive pay (say-on-pay)
394 vote records from 247 filers. 16 of the 239 filers that marked the item voted against management. 8 filers gave no management mark.
- Positions of 40 fund families
- For 39
- Against 1
- Against management 1
Item 3: Frequency of the say-on-pay vote
One year: 228 filers. For: 5 filers. Three years: 4 filers. : 1 filer. Takenoaction: 1 filer. Abstain: 1 filer.
395 vote records from 247 filers. 5 of the 238 filers that marked the item voted against management. 9 filers gave no management mark.
- Positions of 40 fund families
- Split or no vote 40
- Against management 2
Item 4: Audit-related items (auditor ratification)
194 vote records from 94 filers. 0 of the 93 filers that marked the item voted against management. 1 filer gave no management mark.
- Positions of 35 fund families
- For 35
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 2. Say-on-pay | 3. Pay-vote frequency | 4. Auditor |
|---|---|---|---|
| AllianceBernstein | For | Split | No report |
| American Century | Against, against management | Split | For |
| BlackRock and iShares | For | Split | For |
| BNY Mellon | For | Split | For |
| Brighthouse Funds | For | Split | For |
| Charles Schwab | For | Split | For |
| Columbia Threadneedle | For | Split | No report |
| Dimensional | For | Split, against management | For |
| DWS | For | Split | For |
| Equitable | For | Split | For |
| Fidelity | For | Split | For |
| Franklin Templeton | For | Split | For |
| Global X | For | Split | For |
| Goldman Sachs | For | Split | For |
| Guggenheim and Rydex | For | Split | For |
| Invesco | For | Split | For |
| J.P. Morgan | For | Split | For |
| Jackson National funds | For | Split, against management | For |
| Janus Henderson | For | Split | No report |
| John Hancock and Manulife | For | Split | For |
| Lincoln Financial | For | Split | For |
| Macquarie and Delaware Funds | For | Split | For |
| MassMutual | For | Split | For |
| Morgan Stanley, Eaton Vance and Calvert | For | Split | For |
| Nationwide | For | Split | For |
| Natixis and Loomis Sayles | For | Split | No report |
| Neuberger Berman | For | Split | No report |
| Northern Trust and FlexShares | For | Split | For |
| Nuveen and TIAA | For | Split | For |
| Pacific Life funds | For | Split | For |
| PGIM and Prudential | For | Split | For |
| Principal | For | Split | For |
| ProShares and ProFunds | For | Split | For |
| SEI | For | Split | For |
| State Street and SPDR | For | Split | For |
| T. Rowe Price | For | Split | For |
| Transamerica | For | Split | For |
| Vanguard | For | Split | For |
| Victory Capital | For | Split | For |
| Voya | For | Split | For |
Questions
- How many filers reported votes at the Day One Biopharmaceuticals, Inc. meeting?
- 251 Form N-PX filers reported votes at the meeting of 23 May 2024. On say-on-pay, 16 of 239 filers that marked the item voted against management (6.7%).
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. Day One Biopharmaceuticals, Inc. reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Day One Biopharmaceuticals, Inc. with a meeting date within three days of 23 May 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .